Row | STUDYID | DOMAIN | ETCD | ELEMENT | TESTRL | TEENRL | TEDUR |
---|
1 | EX1 | TE | SCRN | Screen | Informed consent | 1 week after start of Element | P7D |
2 | EX1 | TE | RI | Run-In | Eligibility confirmed | 2 weeks after start of Element | P14D |
3 | EX1 | TE | P | Usual Usual | First dose of study drugproduct administration, where drug study product is usual tobacco product | 2 weeks after start of Element | P14D |
4 | EX1 | TE | A | Tobacco Product A | First dose of study drugproduct administration, where drug study product is usual tobacco Tobacco product A | 2 weeks after start of Element | P14D |
5 | EX1 | TE | B | Tobacco Product B B | First dose of study drugproduct administration, where drug study product is usual tobacco Tobacco product B | 2 weeks after start of Element | P14D |
6 | EX1 | TE | FU | Follow-Up | First day of Follow-up after end of study product administration | 1 week after start of Element. | PD7Follow-UP |